Last reviewed · How we verify
NCT05258812
Cytopenias in Hospitalized Patients of Corona Virus Infection(COVID-19) During First and Other Waves
trial in Corona Virus Infection in 202 participants. Completed in 30 June 2021.
30 June 2021
Quick facts
| Lead sponsor | Fatima Memorial Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 202 |
| Start date | 1 May 2020 |
| Primary completion | 30 June 2021 |
| Estimated completion | 30 June 2021 |
| Sites | 1 location across Pakistan |
Conditions studied
- Corona Virus Infection — all drugs for Corona Virus Infection →
Sponsor
Fatima Memorial Hospital
Who can join
Adults 10 to 95, any sex, with Corona Virus Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Demographic, Clinical and laboratory data as well as outcome of total 202 COVID-19 patients who were Polymerase Chain Reaction (PCR) positive and admitted in Fatima memorial Hospital, Lahore, Pakistan, was collected during first and other waves. Data of First wave is from May 2020 to July 2020, second wave from early November to Mid December 2020 and third wave from Mid march to June 2021. Investigator analyzed the data on basis of Systemic immune inflammatory index (SII) as well hematological parameters of First Wave were compared to other waves of COVID-19.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05258812
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Corona Virus Infection
Currently open trials in the same condition.
- NCT05765396 — SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies · active not recruiting
- NCT05684549 — Coronavirus Infection (COVID-19) and Radical Surgery in Patients With Early-stage Lung Cancer · active not recruiting
- NCT04382846 — Novel Regimens in COVID-19 Treatment · Phase 3 · recruiting
- NCT04371315 — Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children · recruiting
- NCT04359836 — A Study to Explore the Role of Gut Flora in COVID-19 Infection · recruiting
Other Fatima Memorial Hospital trials
Trials by the same sponsor.
- NCT07256691 — Effect of Calcium-Based Bioceramic Sealer and Resin-Based Sealer on Postoperative Pain · NA · recruiting
- NCT07479069 — Erector Spinae Plane Block for Pain Control After Open Abdominal Surgery · NA · active not recruiting
- NCT07034300 — Lidocaine vs. Lidocaine With Dexmedetomidine for Intravenous Regional Anesthesia (IVRA) in Upper Limb Surgery · Phase 4 · recruiting
- NCT07022821 — Comparison of Dexmedetomidine + Ketamine for Postoperative Pain in C-Section · Phase 4 · recruiting
- NCT05484726 — Maternal Role in Oral Feed Establishment in Preterm Neonates · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05258812 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fatima Memorial Hospital
- Last refreshed: 28 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05258812.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing